Published Date: 09 Mar 2023
Recent studies have shown poor outcomes in infants and children with postnatal development.
Read Full NewsThe U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...
Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.
Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.
1.
After two years, a significant left nasal obstruction was finally diagnosed.
2.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
3.
In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.
4.
AI could help improve early detection of interval breast cancers
5.
Older Adults With Advanced Cancer Prioritize Quality of Life
1.
Managing Hematoma: A Guide to Prevention and Treatment
2.
Autophagy: A Double-Edged Sword in Cancer Development, Immune Evasion, and Drug Resistance
3.
A Breakthrough in Multiple Myeloma: Darzalex Delays Disease Progression by 51%
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
Prognostic Role of PLAU in Pan-Cancer and Neutrophil Infiltration in Bladder Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
2.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
3.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation